Structural Formula (Cli04 0016 01)
Chemical structure diagram of Clindamycin showing its atomic and bonding arrangement.*
Clindamycin Injection, Solution
Product Images NDC 25021-115
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin (NDC 25021-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label – Principal Display Panel – Vial Label (Cli04 0016 02)
Clindamycin Injection USP label from Sagent Pharmaceuticals showing concentration of 300 mg per 2 mL (150 mg per mL) in a 2 mL single-dose vial. The label indicates it is sterile and for intramuscular or intravenous use, with dilution required before intravenous use. Storage instructions and manufacturer details are included.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
